Deployable, Domestic Manufacturing Technology for COVID-19 Vaccine Component


Waltham, MA – June 11, 2020 – BARDA and Snapdragon Chemistry Inc. of Waltham, Massachusetts, will work together over the next year to develop and demonstrate an innovative continuous manufacturing platform to produce ribonucleotide triphosphates (NTPs), a critical raw material for COVID-19 vaccines that use messenger RNA technology. The project includes a rapidly scalable, continuous manufacturing process for the chemical synthesis and purification of NTPs.

Read the full announcement (via Medical Countermeasures)

About Snapdragon Chemistry
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact